Advertisements

Stocking Stuffers

 

NovaBay Pharmaceuticals Inc. (NBY) Stock Quote

Detailed Quote for NovaBay Pharmaceuticals Inc. (NBY)
$ 1.66 r      -0.41 (-19.81%) Volume: 4.73m 8:00 PM EDT Jun 14, 2019
After Hours:  $ 1.6999   0.0399 (+2.40%) Volume: 69.08k 7:59 PM EDT Jun 14, 2019
Today 5d 1m 3m 1y more
Last Price
1.66
Change $
0.41
Change %
19.81%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
2.06
High
2.08
Low
1.62
Prev Close
2.07
Last Trade
06/14/19
Volume
4.73m
52 Wk Hi
4.03999996
52 Wk Low
0.229000002
Market Cap
31.53m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
18,992,116
EPS (TTM)
-0.569999992
PE Ratio
N/A
Exchange
NYSE American
News and Media for NovaBay Pharmaceuticals Inc. (NBY)
Sector News | Topic News
News for NovaBay Pharmaceuticals Inc. (NBY)
Thu, Jun 13, 2019
9:09 AM SVRA and HEB among premarket losers - SeekingAlpha
Wed, Jun 12, 2019
12:39 PM Microcaps dominate midday movers - SeekingAlpha
Tue, Jun 11, 2019
5:34 PM PLAY leads after hours losers - SeekingAlpha
1:05 PM 4 Biotech Stocks to Watch After Latest Merger and Acquisition Activity - ACCESSWIRE IA
12:41 PM Healthcare tops midday movers - SeekingAlpha
9:21 AM MT, ZYNE among premarket gainers - SeekingAlpha
Mon, Jun 10, 2019
5:38 PM Caseys General Stores among after hour gainers - SeekingAlpha
8:27 AM NovaBay launches Avenova direct on Amazon; shares up 224% premarket - SeekingAlpha
6:50 AM NovaBay Pharmaceuticals Launches Avenova\u00AE Direct on Amazon.com - Business Wire
Tue, May 21, 2019
4:05 PM NovaBay Pharmaceuticals Receives NYSE American Communication - Business Wire
Thu, May 09, 2019
8:05 PM NovaBay Pharmaceuticals, Inc (NBY) CEO Justin Hall on Q1 2019 Results - Earnings Call Transcript - SeekingAlpha
More News for NBY >>
Filings for NovaBay Pharmaceuticals Inc. (NBY)
Thu, Jun 13, 2019
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Wed, Jun 12, 2019
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
3:00 AM Statement of changes in beneficial ownership of securities - Form 4
Mon, Jun 03, 2019
3:00 AM Report of unscheduled material events or corporate changes - Form 8-K
Tue, May 21, 2019
3:00 AM Report of unscheduled material events or corporate changes - Form 8-K
Wed, May 15, 2019
3:00 AM Quarterly report with a continuing view of a company's financial position - Form 10-Q
Mon, May 13, 2019
3:00 AM Report of unscheduled material events or corporate changes - Form 8-K
More Filings for NBY >>

Tags for NovaBay Pharmaceuticals Inc.

Research stocks or mutual funds related to NovaBay Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to NBY. The keywords below have been associated to NBY by either user submission or electronic means.

pharmaceuticals research pharmaceutical branding pharmaceutical industry strategy pharmaceutical publication pharmaceutical market generic pharmaceutical pharmaceutical investment mgi pharma pharma strategy pharmaceutical research and development pharmaceutical advisory boards pharmaceutical industry marketing pharma newsletter pharmaceutical software pharma manufacturing pfizer careers pharma license pharmaceutical supply chain pfizer pharmaceutical company pharmaceutical cro pharma companies pharmaceutical sales pharma pharmaceutical distributors pharmaceutical reports biotech Drugs pharmaceutical auctions pharma r&d pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharma reports biotech profile pharmaceutical proteins pharmaceutical article pfizer pharmaceuticals contract pharmaceutical pharmaceutical consulting research biotech pharmaceutical industry pharmaceutical studies pharmaceutical strategy patent research pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing pharmaceutical co promotion